
|
Heijmen RH, Thompson M, Fattori R, Goktay Y, Teebken OE, Orend KH, on behalf of the Valiant Captivia Registry Investigators The Valiant Thoracic Stent Graft Deployed with the New Captivia Delivery System: Procedural and 30-day Results of the Valiant Captivia Registry. J Endovasc Ther. 2012;19(2):213-225. |
|
Wilhelmi MH, Tiede A, Teebken OE, Bisdas T, Haverich A, Mischke R. Ovine blood: establishment of a list of reference values relevant for blood coagulation in sheep. ASAIO J. 2012 Jan;58(1):79-82. |
|
Bisdas T, Beckmann E, marsch g, Burgwitz K, Wilhelmi M, Kuehn C, Haverich A, Teebken OE. Prevention of vascular graft infections with antibiotic graft impregnation prior to implantation: in vitro comparison between daptomycin, rifampin and nebacetin. Eur J Vasc Endovasc Surg. 2012;43(4):448-456. |
|
Teebken OE, Bisdas T, Assadian O, Ricco JB. Recommendations for Reporting Treatment of Aortic Graft Infections. Eur J Vasc Endovasc Surg. 2012; 43:174-181. |
|
Lombardi JV, Cambria RP, Nienaber CA, Chiesa R, Teebken O, Lee A, Mossop P, Bharadwaj P. Initial results of a prospective multicenter clinical trial (STABLE) on the endovascular treatment of complicated type B aortic dissection using a composite device design. J Vasc Surg 2012;55(3):629-640.e2. |
|
Bisdas T, Bagaev E, Burgwitz K, Marsch G, Wilhelmi M, Haverich A, Teebken OE. In-Vitro Effektivität der Imprägnierung von Gefäßprothesen mit keimspezifischen Bakteriophagen für die Prävention von Protheseninfektionen. Gefässchirurgie 2011;16:387-394. DOI 10.1007/s00772-011-0950-y. |
|
Bisdas T, Beutel G, Hoeper MM, Kuehn C, Warnecke G, Haverich A, Teebken OE. Vascular complications in patients undergoing femoral cannulation for extracorporeal membrane oxygenation support. Ann Thorac Surg 2011;92(2):626-31 |
|
Bisdas T, Wilhelmi M, Haverich A, Teebken OE. Cryopreserved arterial homografts versus silver-coated Dacron grafts for abdominal aortic infections with intraoperative evidence of microorganisms. J Vasc Surg 2011;53(5):1274-1281. (2009 IF 3.517). |
|
Zhang R*, Teebken O*, Ringe K, Wilhelmi M, Bisdas T, Haverich A, Pichlmaier M. Surgical outcome in patients with concomitant infected abdominal aortic aneurysm and spondylitis. Vascular 2011;19(1):34-41.*) First and second author contributed equally. |
|
Bisdas T, Pichlmaier M, Wilhelmi M, Bisdas S, Haverich A, Teebken OE. Effects of the ABO-mismatch between donor and recipient of cryopreserved arterial homografts. Int Angiol 2011;30(3):247-55 (2009 IF 1.155). |
|
Koenneker S, Teebken OE, Bonehie M, Pflaum M, Jockenhoevel S, Haverich A, Wilhelmi MH. A biological alternative to alloplastic grafts in dialysis therapy: evaluation of an autologised bioartificial hemodialysis shunt vessel in a sheep model. Eur J Vasc Endovasc Surg Eur J Vasc Endovasc Surg. 2010 Dec;40(6):810-6. Epub 2010 Jun 8. (2009 IF 2.919). |
|
Bisdas T, Redwan A, Wilhelmi M, Hagl C, Haverich A, Teebken O, Pichlmaier M. Less invasive perfusion techniques may improve outcome in thoracoabdominal aortic surgery. J Thorac Cardiovasc Surg 2010 Dec;140(6):1319-24. Epub 2010 Mar 25 (2009 IF 3.063). |
|
Bagaev E, Pichlmaier MA, Bisdas T, Wilhelmi M, Haverich A, Teebken OE. Contralateral internal carotid artery occlusion impairs early but not 30-day stroke rate following carotid thrombendarterectomy and cardiac surgery. Angiology 2010;61(7):705-710. (2009 IF 1.097). |
|
Bisdas T, Fuchs M, Ott E, Pichlmaier M, Wilhelmi M, Haverich A, Teebken OE. Eight-year experience with cryopreserved arterial homografts for the in situ reconstruction of abdominal aortic infections. J Vasc Surg 2010;52:323-330 (2009 IF 3.517). |
|
Torsello GB, Torsello GF, Osada N, Teebken OE, Ratusinski CM, Nienaber CA. Midterm results from the TRAVIATA registry: Treatment of thoracic aortic disease with the Valiant stent graft. J Endovasc Ther. 2010;17(2):137-50. (2009 IF 2.902) |
|
Bisdas T, Pichlmaier M, Bisdas S, Haverich A, Teebken O. Early neurological outcome after bovine pericardium versus venous patch angioplasty in 599 patients undergoing carotid endarterectomy with or without concomitant cardiac surgery. Vascular 2010;18(3):147-53. (2009 IF 0.873) |
|
Bisdas T, Paraskevas K, Pichlmaier M, Wilhelmi M, Haverich A, Teebken O. Dorsal (posterior) versus medial approach for surgical repair of popliteal artery aneurysms. Angiology 2010;61(3):248-252. (2009 IF 1.097) |
|
Bisdas T, Pichlmaier M, Rustum S, Wilhelmi M, Shrestha M, Haverich A, Teebken OE. Carotid endarterectomy with or without concomitant aortocoronary bypass in elderly patients: an analysis of 599 procedures. Int Angiol. 2010;29(1):47-52. (2009 IF 1.155) |
|
Bisdas T, Mattner F, Ott E, Pichlmaier M, Wilhelmi M, Haverich A, Teebken OE. Significance of infection markers and microbiological findings during tissue processing of cryopreserved arterial homografts for the early postoperative course. VASA 2009;38(4):365-73. (IF 0.867) |
|
Tudorache I, Kostin S, Meyer T, Teebken O, Bara C, Hilfiker A, Haverich A, Cebotari S. Viable vascularized autologous patch for transmural myocardial reconstruction. Eur J Cardiothorac Surg. 2009;36(2):306-11; discussion 311. Epub 2009 Apr 14.PMID: 19369090. (IF 2.397) |
|
Teebken OE, Puschmann C, Breitenbach I, Rohde B, Haverich A. Preclinical development of tissue engineered vein valves and venous substitutes using re-endothelialised human vein matrix. Eur J Vasc Endovasc Surg. 2009;37(1):92-102. PMID: 19008126 (IF 2.919) |
|
Pichlmaier MA, Teebken OE, Khaladj N, Weidemann J, Galanski M, Haverich A. Distal aortic surgery following arch replacement with a frozen elephant trunk. Eur J Cardiothorac Surg. 2008;34(3):600-604. (IF 2.181) |
|
Werdan K, Pilz G, Müller-Werdan U, Maas Enriquez M, Schmitt DV, Mohr FW, Neeser G, Schondube, F, Schafers, HJ, Haverich A, Fraunberger P, Andersson J, Kreuzer E, Thijs LG and the ESSICS collaborators. Immunoglobulin G treatment of postcardiac surgery patients with score-identified severe systemic inflammatory response syndrome--the ESSICS study. Crit Care Med. 2008;36(3):716-723. (IF 6.594) |
|
Khaladj N, Teebken OE, Hagl C, Wilhelmi M, Tschan C, Weissenborn K, Lichtinghagen R, Hoy L, Haverich A, Pichlmaier AM. The role of cerebrospinal fluid S100 and lactate to predict clinically evident spinal cord ischaemia in thoraco-abdominal aortic surgery. Eur J Vasc Endovasc Surg. 2008;36(1):11-19. (IF 3.007) |
|
Pichlmaier AM, Hoy L, Wilhelmi M, Khaladj N, Haverich A, Teebken OE. Renal perfusion with venous blood extends the permissible suprarenal clamp time in abdominal aortic surgery. J Vasc Surg 2008;47(6):1134-1140. (IF 3.770) |
|
Pichlmaier AM, Bagaev E, Lichtenberg A, Teebken OE, Klein G, Bara C, Haverich A. Four chamber pacing in patients with poor ejection fraction but normal QRS durations undergoing open heart surgery. Pacing and Clinical Electrophysiology PACE 2008;31:184-191. (IF 1.590) |
|
Grothusen C, Umbreen S, Konrad I, Stellos K, Schulz C, Schmidt B, Kremmer E, Teebken O, Massberg S, Luchtefeld M, Schieffer B, Gawaz M. EXP3179 inhibits collagen-dependent platelet activation via glycoprotein receptor-VI independent of AT1-receptor antagonism – potential impact on atherothrombosis. Arterioscler Thromb Vasc Biol 2007;27:1-2. (IF 7.221) |
|
Teebken OE, Pichlmaier AM, Karck M, Haverich A. Herz- und thorakale Gefäßverletzungen. Trauma und Berufskrankheit 2007;9(Suppl.2): (online publiziert 11.04.2006: DOI 10.1007/s10039-006-1126y) (CIF* 0.100) |
|
Aper T, Teebken OE, Steinhoff G, Haverich A. Use of a fibrin preparation in the engineering of a vascular graft model. Eur J Vasc Endovasc Surg 2004;28(3):296-302. (IF 1.685) |
|
Aper T, Puschmann C, Mertsching H, Haverich A, Teebken OE. Bioartifizielle Venenklappe: Biokompatibilität in einer Langzeitstudie im Schafmodell. Phlebologie 2004;33:160-165. (IF 1.100) |
|
Teebken OE, Pichlmaier A, Brand S, Haverich A. Cryopreserved arterial allografts for in situ reconstruction of infected arterial vessels. Eur J Vasc Endovasc Surg 2004;27:597-602. (IF 1.685) |
|
Teebken OE, Puschmann C, Aper T, Haverich A, Mertsching H. Tissue-engineered venous valve: Long-term results in a sheep model. Eur J Vasc Endovasc Surg 2003;25(4):305-312. (IF 1.774) |
|
Teebken OE, Mertsching H, Haverich A. Modification of heart valve allografts and xenografts by means of tissue engineering. Transplant Proc 2002;34(6):2333. (IF 0.478) |
|
Teebken OE, Strüber M, Harringer W, Pichlmaier AM, Haverich A. Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients Transplant Proc 2002;34(4):1265-1268. (IF 0.478) |
|
Teebken OE, Mössinger E, Heitmann P, Seeliger H, Scheumann GFW. Transplantation von Adrenocyten als Alternative zur Hormonsubstitution bei Nebenniereninsuffizienz. Acta Chir Austriaca – Eur Surg 2001;33(6):305-311. (CIF 0.153) |
|
Teebken OE, Pichlmaier MA, Haverich A. Cell seeded decellularised allogeneic matrix grafts and biodegradable polydioxanone-prostheses compared with arterial autografts in a porcine model. Eur J Vasc Endovasc Surg 2001;22(2):139-145. (IF 1.484) |
|
Teebken OE, Scheumann GFW. Differentiated hormone secretion and regeneration after selective adrenocortical cell transplantation and bilateral adrenalectomy in the rat. Transplantation 2000;70:836-843. (IF 4.035) |
|
Wittwer T, Pethig K, Heublein B, Teebken OE, Harringer W, Haverich A, Wahlers T. Impact of chronic infection with chlamydia pneumoniae on incidence of cardiac allograft vasculopathy. Transplantation 2000;69(9):1962-1964. (IF 4.035) |
|
Teebken OE, Bader A, Steinhoff G, Haverich A. Tissue engineering of vascular grafts – human cell seeding of decellularized porcine matrix. Eur J Vasc Endovasc Surg 2000;19(4):381-386. (IF 1.565) |
|
Seeliger H, Hoffmann MW, Teebken OE, Tschernig T, Philippens K, Schürmeyer TH, Klempnauer J, Scheumann GFW. Transplantation of H-2Kb-transgenic adrenocortical cells in the adrenalectomized mouse: functional and morphological aspects. Transplantation 2000;69(8):1561-1566. (IF 4.035) |
|
Teebken OE, Karck M, Harringer W, Haverich A. Entnahme der Vena saphena magna für aortokoronare Bypassoperationen – ist die Subkutannaht notwendig? – Is there a need for subcutaneous stitches after saphenectomy for coronary artery bypass grafting? Swiss Surg 2000;6(2):69-73. (CIF* 0.200) |
|
The ATMI Study Group: Marggraf G, Arnold A, Geiger A, Gödje O, Knocks M, Krabbatsch T, Lefering R, Lorenz K, Neugebauer E, Schmitt D, Schnelle K, Teebken O, Tugtekin M. Response to comments and criticism of the concept and the preliminary trial protocol on “Adjuvant therapy of mediastinitis with immunoglobulins after cardiac surgery (ATMI). Eur J Surg (Suppl) 1999;584:79-84. (IF 0.687) |
|
Marggraf G, Neugebauer EA, The ATMI Study Group (Arnold A, Geiger A, Gödje O, Knocks M, Krabbatsch T, Lefering R, Lorenz K, Schmitt D, Schnelle K, Teebken O, Tugtekin M. A multicentre randomized placebo-controlled double-blind study on adjuvant treatment of mediastinitis with immunglobulins (Pentaglobin) after cardiac surgery (ATMI): outline and preliminary study protocol for discussion. Eur J Surg (Suppl) 1999;584:26-32. (IF 0.687) |
|
Teebken OE, Bader A, Steinhoff G, Haverich A. Ein neues Konzept für Ersatzmaterialien in der Gefäßchirurgie. Langenbecks Arch Chir Suppl Kongressbd 1998;115:1256-9. (IF 0.970) |
|
Cremer J, Karck M, Steinhoff G, Hollander D, Teebken O, Zick G, Haverich A. Ischemic preconditioning, in addition to myocardial protection using crystalloid or blood cardioplegia in routine coronary surgery. Thorac Cardiovasc Surg 1998;46(Suppl):298-301. (IF 0.641) |
|
Bader A, Schilling T, Teebken OE, Brandes G, Herden T, Steinhoff G, Haverich A. Tissue engineering of heart valves – human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardiothoracic Surg 1998;14(3):279-284. (IF 0.759) |
|
Cremer J, Teebken OE, Simon A, Hutzelmann A, Heller M, Haverich A. Thoracic computed tomography prior to redo coronary surgery. Eur J Cardiothoracic Surg 1998;13(6):650-654. (IF 0.857) |
|
Cremer J, Steinhoff G, Karck M, Ahnsell T, Brandt M, Teebken OE, Hollander D, Haverich A. Ischemic preconditioning prior to myocardial protection with cold blood cardioplegia in coronary surgery. Eur J Cardiothoracic Surg 1997;12(5):753-758. (IF 0.857) |
|
Scheumann GFW, Heitmann P, Teebken OE, Mössinger E, Mellon SH, Pichlmayr R. Enzymatic properties of transplanted glomerulosa cells. W J Surg 1996;20(7):933-939. (IF 2.077 / 1997) |